Abstract:Insulin plays a significant role in diabetes treatment. Although a huge number of insulin-loaded, glucose responsive nanocarriers have been developed in past decades, most of them showed a lower loading capacity and efficiency due to the weak interaction between insulin and nanocarriers. In this work, a novel insulin -encapsulated glucose-responsive polymeric complex micelle (CM) is devised, showing (i) enhanced insulin-loading efficiency owing to the zinc ions' chelation by nitrilotriacetic acid (NTA) groups of NTA-functioned glycopolymer and the histidine imidazole of insulin, (ii) the glucose triggered pulse release of insulin, and (iii) long stability under physiological conditions. This CM was fabricated by the self assembly of block copolymer PEG-b-P(Asp-co-AspPBA) and glycopolymer P(Asp-co-AspGA-co-AspNTA), resulting in complex micelles with a PEG shell and a cross-linked core composed of phenylboronic acid (PBA)/glucose complexations. Notably, the modified nitrilotriacetic acid (NTA) groups of CM could specifically bind insulin via chelated zinc ions, thus enhancing the loading efficacy of insulin compared to that of nonmodified CM. The dynamic PBA/glucose complexation core of CM dissociates under the trigger of high glucose concentration (>2 g/L) while being quite stable in low glucose concentrations (<2 g/L), as demonstrated by the pulse release of insulin in vitro. Finally, in a murine model of type 1 diabetes, NTA-modified complex micelles loading an insulin (NTA-CM-INS) group exhibited a long hypoglycemic effect which is superior to that of free insulin in the PBS (PBS-INS) group and insulin -loaded complex micelles without an NTA modification (CM-INS) group. This long-term effect benefited from Zn(II) chelation by NTA-modified complex micelles and could avoid hypoglycemia caused by the burst release of insulin. Taken together, this constitutes a highly effective way to encapsulate insulin and release insulin via an on-demand manner for blood glucose control in diabetes.

Glucose-responsive Microgels Integrated with Enzyme Nanocapsules for Closed-Loop Insulin Delivery.

Ultrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsules

Glucose-Responsive Nanosystem Mimicking the Physiological Insulin Secretion via an Enzyme–Polymer Layer-by-Layer Coating Strategy

An Injectable and Glucose-Sensitive Nanogel for Controlled Insulin Release

Injectable Nano-Network for Glucose-Mediated Insulin Delivery.

Glucose and H2O2 dual-sensitive nanogels for enhanced glucose-responsive insulin delivery

A Fluorescent Responsive Hybrid Nanogel for Closed-Loop Control of Glucose.

Engineering Synthetic Insulin-Secreting Cells Using Hyaluronic Acid Microgels Integrated with Glucose-Responsive Nanoparticles

Injectable dual glucose-responsive hydrogel-micelle composite for mimicking physiological basal and prandial insulin delivery

Glucose-responsive microgels based on apo-enzyme recognition

Glucose-Sensitive And Blood-Compatible Nanogels For Insulin Controlled Release

Highly stable and degradable multifunctional microgel for self-regulated insulin delivery under physiological conditions.

Bio-Inspired Synthetic Nanovesicles for Glucose-Responsive Release of Insulin

Glucose- and Temperature-Responsive Core–shell Microgels for Controlled Insulin Release

Controlled Release of Insulin Based on Temperature and Glucose Dual Responsive Biomicrocapsules

Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery

Injectable Self-Assembled Peptide Hydrogels for Glucose-Mediated Insulin Delivery

Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.

A glucose-sensitive microgel operating at physiological conditions for glucose detecting and insulin delivery

A Novel Insulin Delivery System by Β Cells Encapsulated in Microcapsules.

Nitrilotriacetic Acid-Functionalized Glucose-Responsive Complex Micelles for the Efficient Encapsulation and Self-Regulated Release of Insulin